The leader in the business of psychedelics, Microdose is taking the next step in top-notch industry events with Wonderland 2022. Pulling off such a massive undertaking wouldn’t be possible without the support of our sponsors, they are crucial to both the Wonderland event and the future of the psychedelic medicine industry.
So it’s an honor for Microdose to announce our line-up of top-notch sponsors. This truly would not have been possible without them.
Algernon is a drug re-purposing company that investigates safe, already approved drugs, including naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets. Algernon specifically investigates compounds that have never been approved in the U.S. or Europe to avoid off-label prescription writing.
MindBio is a clinical-stage company pioneering microdosing LSD clinical trials, having just completed Phase 1 in 80 healthy participants and moving to two Phase 2 Clinical Trials in Major Depressive Disorder and another trial in Cancer Patients suffering end of life distress. MindBio is developing and testing a psychedelic microdosing treatment model to effectively and appropriately target individual patients with mental health disorders.
Ninnion is a CNS pharmaceutical drug discovery & development company focused on next generation psychedelic molecules designed for the payer reimbursed market. The company has filed patent applications on its first molecule, NIN-S119, a psilocybin-like psychedelic molecule it will use in its upcoming human clinical trials in ischemic stroke recovery. To build out its IP portfolio, Ninnion signed an exclusive AI drug discovery platform collaboration with a clinical focus on brain injury, chronic pain, inflammation, and addiction disorders.
Enveric Biosciences (NASDAQ: ENVB) is a biotechnology company dedicated to the development of novel small-molecule therapeutics for the treatment of anxiety, depression and addiction disorders. Enveric is committed to developing novel treatments to transform the lives of patients living with mental illness. We are pursuing new pathways and targeting impaired neural circuitry with the goal of improving brain health. Our mission is to pioneer new and innovative solutions with the potential to have profound effects on patients and their families, and to deliver life-changing medicines for diseases affecting the brain
Advancing Health & Wellness Through Clinical Research. Since 1997, KGK Science has played a key role in the natural health product industry by providing our clients with high-quality clinical research and regulatory expertise to bring safe and effective products to global markets. As a full-service premium contract research organization (CRO) supporting the nutraceutical, cannabis and hemp industries, KGK is one of the most reliable resources for brands looking for an experienced, trustworthy team of scientific researchers, consultants, and regulatory specialists to develop customized claim substantiation and path-to-market strategies.
Mindstate Design Labs
Launched out of Y Combinator in 2021, Mindstate Design Labs is a preclinical-stage psychedelic drug development company designing states of consciousness for mental health therapeutics. Recognizing the acute subjective experience of an altered state as central to treatment outcomes, the company is mapping the biological basis of the varieties of psychedelic experience. Mindstate’s target discovery and phenotypic screening platform Osmanthus is powered by human experience, combining natural history, natural language processing, and biochemical data in a predictive model that enables the precision design of modified conscious states.
MycoLife is a beacon for those entering the adaptogens community. Wether you’re new to the industry or a seasoned veteran looking to extend your network, MycoLife is here to serve your every need.
We offer everything you need to grow mushrooms. From isolated cultures to the perfect growing medium targeted for gourmet and medicinal mushrooms. In addition, we sell Mushroom compost for a variety of plants. Our organic substrate has been tested and altered for over 17 years now to become a highly nutritious, mycelium thriving, well blended formula. Steam pasteurized for four hours at an internal temperature of 150f and bagged at field capacity, MycoLife Substrate is ready to grow in the bag or used in a container of choice.
Established in 2020, Circadian Wellness is a group of mindfully cultivated experts who have come together to change the world by harnessing the unrivalled potential of mushrooms to safely and sustainably bring health and wellness to people worldwide. Amplified by cutting-edge technology, Circadian Wellness creates products that not only support wellness, but create lasting change in the body’s regulatory processes, empowering our own natural mechanisms. Circadian Wellness is dedicated to bringing natural remedies to help people:
Cybin is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches, and treatment regimens for psychiatric disorders. The company advances mushroom-based psychedelic pharmaceuticals and non-psychedelic nutraceutical products for diverse markets as potential therapies for various psychiatric and neurological conditions.
Since its inception in 2015, Third Wave has been on a mission to share trusted content, education, and resources to support the intentional and responsible use of psychedelic substances. Our vision is to help co-create a global movement that embraces psychedelic use as a way to heal ourselves and our world. By delivering research-based content, fostering aligned partnerships, educating both consumers and practitioners, and aggregating industry-leading providers, we are on a quest to pioneer cultural awakening through personal transformation.
Beautiful Space exists to connect people with love, community and nature as a whole. By doing so, we see the beauty of family extend to a sustainable planet and a secure future for all children. After decades of working in the community online and offline, globally and locally we know that by focusing on relationship wellness we are doing our bit for a sustainable future
NFP is a global property and casualty broker, benefits consultant, wealth manager, and retirement plan advisor enabling client success through expertise, investments in technology and strong industry relationships.
Stifel GMP and Stifel FirstEnergy are recognized as leaders in Canadian capital markets, with a focus on Consumer & Retail, Diversified Industries, Energy, Financial Services & Financial Sponsors, Life Sciences & Healthcare, Metals & Mining, and Technology. We consistently rank among the top firms in Canada for both mergers & acquisitions advisory and common equity underwriting.
Driven towards future healing and wellbeing, DoseConnect is a first-of-its-kind talent company solely focused on psychedelic therapeutics. Blending organizational strategy, systems thinking, and talent acquisition grounded in conscious connection, DoseConnect is built to help companies in this space scale for hyper-growth. Working directly with founders, visionaries and high-level operators, the team at DoseConnect helps companies with everything from human resources systems and compliance to growth culture transformation. DoseConnect is founded by Dom Farnan, CEO and Erica Downing, COO – the dynamic duo behind DotConnect, an 2021 Inc5000 company focused on talent acquisition and retention. For more information, please visit www.doseconnect.io
Entheo Digital is introducing a best-in-class VR Therapeutic for facilitating non-ordinary states of consciousness. Tracking towards FDA clearance by 2025, SoundSelf uses a biometric feedback loop between the voice and breath, and has been measured to produce transpersonal states of consciousness after 15 minutes of immersion. Entheo is distributing SoundSelf clinically as an adjunct for transformative therapy.
Decentralized Psychedelic Therapy Impact Fund governed by a limited series of NFT’s. DAO governed, we focus on early investment into companies seeding the future of mental health & wellness. Trippy.vc founders and its stakeholders are hands on: We own and operate healing properties in Israel and Miami, with openings planned in Jamaica as well. Participants in the fund purchase a limited edition NFT. Each NFT represents a governance vote and access to the Trippy.vc properties, events, and future capital events. Our Founder series is sold out. Trippy.vc “seeds” series will soon be announced.
Cubed Biotech Inc
Cubed Biotech is a Canadian company that intends to develop & produce psychedelic medicine inspired by historical ethnobotany to disrupt the current treatments of mental illness & addiction. Subject to required regulatory approvals and exemptions, the Company intends to cultivate, extract and also synthesize natural entheogens (Psilocybin from Mushrooms, Mescaline from Cacti, and Ayahuasca’s DMT & MAO-inhibitors), manufacture mental-health & addiction medications, and develop its own proprietary compound through clinical trials for pharmaceutical-grade distribution and commercialization. Please visit www.cubedbiotech.com for more information.
EntheoTech is a Canadian bioscience company focused on innovative psychedelic solutions for chronic pain and mental health. ET is providing interventional pain treatments, Ketamine-assisted therapies and is engaged in the research and development of natural psilocybin formulas with their own unique strain library to promote optimal brain health and the reduction of chronic pain, mental health conditions, and opioid overuse.
Psilera Inc. is a psychedelic-based biotechnology company developing its proprietary neuromodulator pipeline to target mental health disorders. With a proven and award-winning executive team, Psilera leverages research strengths from the pharmaceutical and cannabis industries to repurpose psychoactive natural products into patient-centric treatments. New formulations tailoring the therapeutic effects of DMT will improve treatment scalability and patient compliance further expanding addressable markets. Psilera’s technology platform (BRAIN) will identify next-generation compounds that have modified psychedelic and therapeutic effects in the areas of mood, cognitive, and substance use disorders.
Ketamine Clinics Los Angeles
Ketamine Clinics Los Angeles is a world-renowned ketamine clinic. KCLA was among the first ketamine clinics to open in the U.S. in 2014. Cofounded by Dr. Steven L. Mandel and COO Sam Mandel, they have provided more than 14,000 infusions to over 4,000 patients. KCLA is also the first and only Ketamine Clinic to be accredited by AAAASF, establishing the gold standard for patient comfort, safety, and optimum treatment outcomes. With a full-time team of 15 staff comprised of specialties in anesthesiology, psychiatry, advanced practitioners, nurses, and administrative staff, KCLA provides compassionate, individualized, high-quality care in a state-of-the-art facility.
Numinus develops and delivers transformative, proprietary psychedelic therapeutics, inspired by tradition and informed by science. These are developed through our own laboratory and R&D process and offered through a global network of physical locations, digital solutions and partnerships. Numinus comprises Numinus Bioscience and Numinus Health. Numinus Bioscience is a global leader in psychedelics R&D and analytics that is foundational in building the industry by facilitating and supporting internal and external development goals. Numinus Health is a clinic network providing a wide range of psychedelic and non-psychedelic services for comprehensive, holistic mental health treatment.
Negev Capital is a psychedelic medical intervention investment fund with assets of USD$30+ million. The Company invests in drug discovery, with a focus on preclinical and/or Phase 1 stages of development. They aim to support those early-stage companies in need of capital that promote the thoughtful, responsible, medical use of psychedelic medication for psychiatric disorders, and who have excellent management and science teams, and solid IP.
Seelos Therapeutics (formerly Apricus Biosciences) is focused on finding treatments for central nervous system disorders and rare diseases. It has a portfolio of about a half-dozen candidates, about half of which are in clinical trials. Its pipeline targets such ailments as Parkinson’s Disease, Sanfilippo Syndrome, post-operative pain, and suicidality in post-traumatic stress disorder and major depressive disorder.
Psydelve is a unique NFT art collection that allows users to experience reimagined mushroom trips. Our art consists of magic mushrooms, rendered to life in 3D, as well as animated illustrations from talented artists across the globe. Our classic character art, in the form of extra-dimensional beings, accompany the users on their journeys. We started the Compassionate Care Fund, working closely with our partners at Entheotech, AfterGlo, and Canada House to provide medical access to psychedelic treatment and fund research in the field. Holders of our NFTs will also have access to a wealth of educational resources ranging from crypto to mycology.
Better U is an alternative mental health organization dedicated to increasing access and awareness to breakthrough treatments. Our mission is to transform mental health and reform psychiatry from the diagnose and treat illness model to a thought expansion, neurological reset and spiritual health model by addressing the core causes of depression, anxiety, chronic stress and chronic pain. By utilizing psychedelic therapy, functional neurology, and other alternative mental health modalities, we provide the tools to enhance our greatest ability, self-healing.
Woke Pharmaceuticals Pty Ltd is an Australian-based company focused on the development and commercialisation of novel psychedelic therapies for the treatment of mental health disorders. The Company is developing a novel micro-dose capsule of psilocybin (WP001) for a Phase IIB trial to treat moderate depression. The Principal Investigator is Dr Vince Polito at Macquarie University NSW. The Company’s other novel psilocybin formulation is a high-dose tablet (WP002) with concomitant psychotherapy. The Company plans to conduct multiple studies of WP002 including a Phase IIB in patients with treatment-resistant depression.
Ceruvia Life Sciences
Ceruvia Lifesciences is focused on the discovery, development, and commercialization of psychedelic medicines to deliver meaningful relief to patients suffering from hard-to-treat headache disorders and OCD. The Company is pursuing clinical trials to treat those conditions using synthetic psilocybin and BOL-148, a non-psychedelic LSD derivative, which appear to produce better results than current treatments.
Segal Trials is a 23-year-old Clinical Research site network with multiple Phase I-IV sites throughout South Florida. We have helped get FDA approval for over 55+ medications or devices since 1999. Our team consists of 200+ dedicated research professionals specializing in Psychiatry, Neurology, Addiction, Women’s health, Infectious disease, Senior Living Division, and Psychedelic-based trials. Our mission is to help advance medicine for today and future generations. Together we can make a difference!
The #1 Growth Platform for Ketamine Providers is Here. Ketamine Media helps you raise awareness at scale in the most relevant and authentic way possible. We are pioneers in the digital landscape for innovative new treatments in mental health.
PharmAla Biotech is a Canadian biotechnology company dedicated to the domestic research & development of clinical-grade LaNeo MDMA and novel MDXX compounds in service to the scientific research community.
We are currently the only publicly traded company in the world manufacturing GMP MDMA for use in global clinical trials and expanded access programs, and our LaNeo MDMA is being supplied to multiple clinical trials around the world.
Zuber Lawler, one of the most selective law firms in the United States, represents clients throughout the world from offices in Austin, Chicago, Denver, Los Angeles, New York, Phoenix, and Silicon Valley. In addition to representing a long list of Fortune companies, as well as funds and government entities, Zuber Lawler has represented leading plant medicine companies for over 16 years, and practices at the cutting edge of psychedelics law. Zuber Lawler is uniquely situated to manage psychedelics IPOs; M&A and other deals; intellectual property; FDA and other regulatory work, and litigation. The firm’s attorney roster includes bioscience PhDs and engineers, and a literal former rocket scientist. Its attorneys work in languages covering 90% of the world’s population. www.zuberlawler.com. Zuber Lawler is also a founder of the magazine Psychedelia.
IMIO is dedicated to identifying and refining the use of psychedelic molecules to better treat chronic pain. The approach is to combine known molecules with our proprietary BTLS drug delivery technology, enabling better penetration of molecules into the brain, reducing the therapeutic dose, and providing a safer treatment while minimizing adverse effects.
Bienstar is dedicated to transforming the patient experience in mental health care and accelerating access to evidence-based innovation. We have a drug abuse care treatment center with 27 years of experience in the use of Ibogaine. From Latam, we want to bring the knowledge accumulated in this region to the world and offer Latam patients new alternatives in resistant depression treatments.
Purisys is a leading supplier of active pharmaceutical ingredients (APIs), contract development and manufacturing (CDMO) services, and pharmaceutical reference materials. Its 17,000-square-foot manufacturing facility and innovation center in Athens, Georgia is staffed by scientists and other professionals who have decades of experience in complex high-barrier custom synthetic chemistry. Purisys has specialized expertise in controlled substances, including psychedelics, for registered cGMP pharmaceutical applications. This specialized expertise is complemented by its extensive regulatory filing experience and know-how to produce dozens of APIs across multiple categories and indications. The company offers a fully operational global supply chain and exports to over 30 countries with full international regulatory compliance. Purisys’ CDMO services are designed to support the development of custom APIs for a wide range of clinical and commercial applications, linking product development services, analytical support, and cGMP manufacturing in an integrated process. To learn more about Purisys’ products and services, visit https://purisys.com/.
MUSHEE Medicinal only utilizes U.S.- grown Mushrooms; users are healing the best versions of themselves and getting closer to that most authentic self each day. MUSHEE Medicinal represents the light parts of us, the features we want to accentuate, and the regions we want to heal. By utilizing functional mushrooms to ensure that anyone can use in an easy and tasty dose. They are lab tested, organic, gluten-free, kosher, vegan, and alcohol-free. One major differentiator is our non-GMO plant based glycerin formula used in every bottle and our whole fruiting body mushroom proprietary extraction method.
We are here to facilitate an increase in awareness and consciousness as we blend Western medical and psychotherapeutic methods with diverse Eastern and Indigenous practices. Working with the treatment can allow for clarity, healing, insight, and creating with choice. We are here to let you know there is another way.
We are a VC fund dedicated to the mind: our mental and neurological health. We invest in brilliant founders solving humanity’s most prevalent and damaging problems.
Irwin Naturals Emergence
Irwin Naturals Emergence seeks to become the world’s premier chain of psychedelic mental health clinics and arrive at 100 clinics and beyond as a first-mover before anyone else. Today, it operates the largest specialized chain of clinics in this emerging new space. The company intends to be a thought leader by establishing best practices to maximize treatment outcomes and to use economies of scale to lower treatment costs, both for direct-pay patients as well as insurance companies.
Healing Maps was created as a source for individuals looking for accurate and honest information about psychedelic-assisted therapy (including integrative mental health, ketamine clinics across the United States as well as retreats globally) and qualified providers in their area. Inspired by the groundbreaking research and expanding access to treatment, Healing Maps is on a journey to become the world’s most informative and trusted psychedelic-therapy search site. Healing Maps will provide content and information to patients to educate them on the alternatives available to legally treat their ailments, find clinics that can offer those services and buy products that can assist them in their healing journey.
The Patient Recruiting Agency
For over 20 Years, The Patient Recruiting Agency has worked for Investigators, CROs, and Sponsors recruiting over 10,000 patients of all ages/races in multiple languages for over 150 indications. A full-service global recruiting/retention company, specializing in creative and fulfillment of branding, study materials, media campaigns, websites, online pre-screeners, and RADIUS365. All services are provided IN-HOUSE! Experienced. Flexible. Scalable.
Intiem is the world’s pioneering psychedelic pharmaceutical provider for healing sexual-dysfunction disorders.
WholeSun Wellness is a woman-owned and operated company committed to delivering the highest quality whole mushroom fruiting body extracts for consumers and bulk customers. In an unregulated industry, WholeSun Wellness is setting higher standards for functional mushrooms on a global scale. We proudly partner with our mushroom farmers directly, maintain complete traceability and transparency, and guarantee levels of active compounds not found anywhere else. Novel testing parameters developed by our partner research lab Alita Bioscience, and our expanding vertically-integrated U.S. mushroom farms are just two ways we are pushing for greater quality and accountability in the industry.
Spine and Wellness Centers of America
Dr. Michelle Weiner is double board-certified in Interventional Pain Medicine and Physical Medicine and Rehabilitation. She completed her residency and fellowship training at the University of Miami. She is a member of Florida’s Medical Cannabis Advisory Committee. Dr. Weiner’s unique approach of personalized and preventative medicine focuses on empowering her patients to cultivate health using lifestyle and plant medicine. Her research focuses on using cannabis as a substitute for opioids in chronic pain patients and cannabis’s effect on seniors with chronic pain. She is faculty and a preceptor at Nova Southeastern University in which she educates the medical students through shadowing opportunities in her office. Dr. Weiner is the Vice President of Mr. Psychedelic Law, a not-for-profit with the mission of responsible legal reform of psilocybin mushrooms in Florida. She uses cannabis and ketamine-assisted psychotherapy as a catalyst to identify the root cause of one’s suffering optimizing their quality of life.
Based in Las Vegas, Nevada, Psilo Mart a 100% LEGAL line of smokable and edible Medicinal Mushroom products. We utilize varieties of Amanita Mushrooms to extract a legal psychedelic compound called Muscimol that produces effects similar to Magic Mushrooms or Psilocybin. Simply put, you get the body buzz without the visuals. COAs are included with every order to ensure their compliance with all requirements pertaining to the Alternative Products Market.
Success TMS offers a modern, med-free treatment for depression. Transcranial Magnetic Stimulation (TMS) is a therapy that is FDA-approved, proven more effective than meds, and covered by almost all health insurance companies and medicare. Get relief in as little as 8 weeks. Contact us today for a free consultation.
Tripper Clothing Co
Tripper is a clothing brand for psychedelic adventurers that brings together the love of all things outdoors and the psychedelic movement. Tripper supports environmental conservation and psychedelic research. Our mission is to create a cultural shift that embraces the spirit of connectedness with the earth and ourselves. Together, we seek the unknown.
H.C. Wainwright & Co.
H.C. Wainwright & Co. is one of the country’s oldest and most trusted financial institutions.
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research to address conditions, such as depression, post-traumatic stress disorder, Parkinson’s, and other rare neurological disorders. It also offers NFID (No Found Identification) branded apparels, which include sweatshirts, hoodies, T-shirts, jackets, and hats. The company entered into a scientific research agreement with the University of Maryland.
Our goal is to remove the barrier to entry when it comes to accessing *organic mushrooms, health-oriented supplements and education on psychedelics.
From our soft gels to our gummies, all of our products are made using *organic mushrooms and minimal, high-quality ingredients. We want our customers to have a top-tier experience, whether it’s your first time trying an incredible blend or your zillionth. We’re here to make health accessible.
WCI Health LLC
WCI Health is an alternative health and wellness company created to address the misconceptions surrounding medicinal herbs like psilocybin and other entheogens. WCI health specializes in providing an evidence-based virtual educational platform where clients can learn how to get and stay well using the healing power of plant medicines, adaptogens, and other wellness tools; thereby saving on healthcare costs and living a stress-free life. WCI Health provides services that are generally tailored to individual clients including, health and wellness coaching, corporate staff training, brand building, and community empowerment using their youth mentorship programs.
Hunter + Esquire
Hunter + Esquire launched in 2017 as a boutique retained executive search firm with the goal of helping the most aspirational cannabis businesses break through the very unique and complex leadership hiring challenges facing the industry. In early 2020, H+E expanded to serve the psychedelics industry in the same way. Our approach is to partner with our hiring clients in a holistic manner where we are given the opportunity to also advise broadly on a full-spectrum of Human Capital topics such as workforce planning, employee relations / talent retention, job description creation / measurements of success and compensation package structuring.
An entrepreneurial international insurance brokerage and risk consulting firm. “Our purpose is to help Canadian businesses be more competitive and assist individuals in preserving their wealth wherever they may be.” Servicing all sectors of the Canadian economy with specialization in Healthcare, Lifesciences, Financial Institutions, Technology, Real Estate, Advanced Manufacturing, Hospitality, Professional Services, InsurTech/FinTech, Equine, Transportation, and Association Programs.
Cacti is a preclinical stage biotech company developing next-generation psychedelics for treatment of chronic pain, inflammation and headache. Led by CEO, Kaitlin Roberson, our team of Harvard-trained neuroscientists and chemists has over 30 years combined experience developing novel medicines from concept through clinical trials, as described in their recent top tier scientific publications in Nature, Cell, Nature Neuroscience and on the December 2022 cover of PAIN. By leveraging the latest machine learning drug discovery tools, we aim to bring psychedelic therapies for pain and headache to patients worldwide.
PsyRx, a psychedelic pharmaceuticals company based in Israel and Licensed by the Israeli Ministry of Health to conduct R&D in the psychedelic substances Psilocybin and Ibogaine, utilises bioreactor technology to become a leading producer of GMP standard Ibogaine and Psilocybin. PsyRx intends to use these psychedelic substances to launch the development of an anti-depressant drug based on the combination of micro-doses of psychedelics with existing approved antidepressants, to reduce intake time and to improve efficacy, whilst minimizing side effects and without causing a psychedelic experience.
Earth and Star
Zoe and Erica here, founders of BluePrintCleanse–remember when everyone was doing a juice cleanse and then you started seeing cold-pressed green juice on store shelves everywhere? Well you can thank (or blame) us for that! We’re on a constant quest to find what actually works to improve your health, and we couldn’t be more excited about functional mushrooms. We feel they haven’t truly had their moment in the sun (or shade, as the case may be), so we created earth & star to deliver these incredible benefits to you in the products that you already use every day. We like to think our specialty is taking what works, (however weird!), and bringing it to you in a way you can understand, that also happens to be totally delicious. We believe the future is fungi, so we are thrilled to introduce you to Earth & Star®.
Heroic Hearts Project
The mission of Heroic Hearts Project is to build a healing community that helps veterans suffering from military trauma recover and thrive by providing them with safe, supervised access to psychedelic treatments, professional coaching, and ongoing peer support.
Founded in 1986, the Multidisciplinary Association for Psychedelic Studies (MAPS) is a 501(c)(3) non-profit research and educational organization that develops medical, legal, and cultural contexts for people to benefit from the careful uses of psychedelics and marijuana.
Nue Life Health
Nue.life is a next-gen mental wellness company that believes in the power of psychedelics to catalyze lasting change.
The New Health Club
The New Health Club is here to inform and support. The New Health Club Show talks to thought leaders, innovators and disruptors from the new world of psychedelics. We help you to learn about everything important, from microdosing to psychedelic retreats. We believe in its benefits of health, lifestyle, and wellness optimization with the support of psychedelics – if it’s done right.
Grow Medicine offers the medicine community an opportunity to embody the practice of right relationship by making a donation to trusted organizations that support Indigenous sovereignty, plant medicine conservation, and supports biocultural diversity to thrive for generations to come.
We help to inform and educate the medicine community about the impact of our choices around plant medicine consumption including the risks and threats that these biocultures face and help to broaden the conversation around plant medicine conservation to be inclusive of the symbiotic relationship between plants, land, and communities.
Wondermed is a vertically integrated healthcare platform and mental health treatment protocol that leverages low-dose, at-home ketamine for the relief of anxiety & depression. Wondermed is a subsidiary of Wonder Sciences, a health-tech company pioneering the intersection between psychedelic medicine and science.
No Fallen Heroes Foundation
No Fallen Heroes is the eye-opening story of real TOPGUN pilots who are finding a new way to win those dark battles. The upcoming movie reveals an ancient method that’s providing near-instant healing from the trauma that veterans endure. Amazingly, it’s psychedelic medicine.
lsd ketamine dmt ayahuasca mescaline ibogaine psychoactive psychedelics psychedelic psilocybin mdma cybin seelos therapeutics silo pharma numinus seelos silo algernon pharmaceuticals algernon irwin naturals mushroom psilera ceruvia lifesciences wondermed nue life health